Lakewood-Amedex Biotherapeutics Inc. Common Stock
Support and Resistance Levels
Past performance
News About LABT
All events for LABT
All deals for LABT
Financial Ratios
Financial Statements
LABT vs Sector & Peers
About Lakewood-Amedex Biotherapeutics Inc. Common Stock
This biopharmaceutical company is dedicated to developing innovative antimicrobial therapies. Its array of anti-infective products is designed to tackle specific viral conditions, including avian influenza, Epstein-Barr Virus (EBV), and hepatitis B and C. Established by Roderic Dale on July 11, 2006, the firm maintains its principal office in Bradenton, Florida. Website lakewoodamedex.com
Headquarters University Park, FL, US